Crownbio is a company headquartered in China.
Crownbio is a contract research organization specializing in translational oncology and immuno-oncology drug discovery and development, providing preclinical and translational services including 3D models, bioanalysis, bioinformatics, and in vivo and in vitro cancer models.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.